Non-invasive Raman measurement apparatus with broadband spectral correction

• US 20060211926A1
• Filed: 03/21/2005
• Published: 09/21/2006
• Est. Priority Date: 03/21/2005
• Status: Abandoned Application

• Current Assignee: Dejin Yu, Yang Wei
• Original Assignee: Dejin Yu, Yang Wei
• Inventors: Yang, Wei, Yu, Dejin
• Application Number:
  US11/085,751
• Publication Number:
  US 20060211926A1
• Time in Patent Office: Days
• US Class Current: 600/316
• CPC Class Codes: A61B 2560/0223 of calibration, e.g. protocols for calibrating sensors
• CPC Class Codes: A61B 2562/146 for optical coupling
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters

Abstract

The present invention discloses a method and apparatus in relation to non-invasive measurement of human blood analytes such as glucose using Raman Spectroscopy. The method is intended to correct for errors associated with varying skin conditions. An approach is described for generating a skin/tissue function that accounts for light energy dissipation due to skin and tissue interferences such as color, thickness, sites, oily, turbid, and surface roughness, etc. The measured skin/tissue function is utilized to correct Raman spectra, thus removing uncertainty and ambiguity coming from skin conditions. The method comprises measuring incident broadband spectrum and diffuse reflectance spectrum, and from them calculating the skin-tissue function.

Claims

1. An apparatus for non-invasively evaluating constituents under the skin of a patient comprising:

a first measurement module including a light source for illuminating the target tissue and a first detector for monitoring the optical response of the tissue, said measurement module being selected from the group consisting of Raman spectroscopy, infrared spectroscopy, infrared spectroscopy, fluorescence spectroscopy, polarization changes and scatter changes;

a second measurement module including a broadband light source for illuminating the target tissue and a second detector for monitoring the optical response of the tissue; and

a processor for receiving the output from said first and second detectors and operating to calculate a reflectance spectrum based on the output from the second detector and using that spectrum to correct the output from the first detector when evaluating the constituents in the patient.

2. An apparatus as recited in claim 1, wherein said first and second detectors are the same.

3. An apparatus as recited in claim 1, further including an optical path for monitoring the intensity of the light emitted from the broadband light source and wherein said processor uses that information to normalize measurements of the second detector.

4. An apparatus as recited in claim 1, wherein said first measurement module is configured to perform Raman spectroscopy.

5. An apparatus as recited in claim 4, wherein the illumination power of the broadband light source is below the Raman threshold.

6. An apparatus as recited in claim 5, wherein the processor functions to evaluate the glucose level in blood.

7. An apparatus for non-invasively evaluating the constituents in the blood of a patient comprising:

a laser light source for selectively illuminating the target tissue with narrow band optical radiation;

a broadband light source for selectively illuminating the target tissue with broadband optical radiation;

a spectrometer detector for monitoring the Raman spectral response from the target tissue when illuminated by the laser light source and for monitoring the spectral reflectance of the target tissue when illuminated by the broadband light source; and

a processor for using the monitored spectral reflectance to correct the Raman spectral response and for evaluating the constituents in the blood using the corrected Raman spectral response.

8. An apparatus as recited in claim 7, further including an optical path for monitoring the intensity of the light emitted from the broadband light source and wherein said processor uses that information to normalize measurements of the broadband light reflected from the target tissue.

9. An apparatus as recited in claim 8, wherein the illumination power of the broadband light source is below the Raman threshold.

10. An apparatus as recited in claim 9, wherein the processor functions to evaluate the glucose level in blood.

11. An apparatus as recited in claim 7, wherein the wavelength range of the broadband light source includes the wavelength emitted by the laser light source and at least a portion of the Raman shifted wavelengths.

12. An apparatus for non-invasively evaluating the constituents in the blood of a patient comprising:

a laser light source;

a broadband light source;

a spectrometer detector;

optics for selectively directing the laser light to the target tissue and the Raman spectral response to the detector, said optics for selectively directing the broadband light to the target tissue and the reflected light to the detector, said optic also selectively directing the broadband light to the detector without reflecting off the target tissue; and

a processor for generating a normalized reflectance spectrum using both measurements of the broadband light and using the normalized reflectance spectrum to correct the Raman spectral response and for evaluating the constituents in the blood using the corrected Raman spectral response.

13. An apparatus as recited in claim 12, wherein the illumination power of the broadband light source is below the Raman threshold.

14. An apparatus as recited in claim 13, wherein the processor functions to evaluate the glucose level in blood.

15. An apparatus as recited in claim 12, wherein the wavelength range of the broadband light source includes the wavelength emitted by the laser light source and at least a portion of the Raman shifted wavelengths.

16. A method for non-invasively evaluating the constituents in the blood of a patient comprising the steps of:

illuminating the target tissue with broadband light;

monitoring the spectral response of the tissue to the broadband illumination;

illuminating the target tissue with narrowband light;

monitoring the Raman spectral response to the narrowband light;

correcting the Raman spectral response using the monitored spectral response to the broadband light; and

evaluating the constituents in the blood using the corrected Raman spectral response.

17. A method as recited in claim 16, further including the steps of:

measuring the spectral intensity of the broadband light incident on the target tissue; and

normalizing the spectral response of the tissue to broadband light with the measurement of the spectral intensity of the incident broadband light.

18. A method as recited in claim 16, wherein the illumination power of the broadband light source is below the Raman threshold.

19. A method as recited in claim 16, wherein the constituent is glucose.

20. A method as recited in claim 16, wherein the wavelength range of the broadband light source includes the wavelength emitted by the laser light source and at least a portion of the Raman shifted wavelengths.

21. An apparatus for non-invasively evaluating the constituents in the blood of a patient comprising:

a laser light source for selectively illuminating the target tissue with narrow band optical radiation;

a second light source for selectively illuminating the target tissue with optical radiation having at least one wavelength;

a spectrometer detector for monitoring the Raman spectral response from the target tissue when illuminated by the laser light source and for monitoring the spectral reflectance of the target tissue when illuminated by the light from the second source; and

a processor for using the monitored spectral reflectance to correct the Raman spectral response and for evaluating the constituents in the blood using the corrected Raman spectral response.

22. An apparatus as recited in claim 21, further including an optical path for monitoring the intensity of the light emitted from the second light source and wherein said processor uses that information to normalize measurements of the light from the second source reflected from the target tissue.

23. An apparatus as recited in claim 21, wherein the illumination power of the light from the second source is below the Raman threshold.

24. An apparatus as recited in claim 21, wherein the processor functions to evaluate the glucose level in blood.

25. An apparatus as recited in claim 21, wherein the wavelength emitted by the second source is selected to either match the narrow band output of the laser light or fall within the range of the Raman shifted wavelengths.

26. An apparatus as recited in claim 21, wherein said second light source is arranged to emit a plurality of distinct wavelengths and wherein the Raman spectral response is corrected using measurements at more than one wavelength.

27. A method for non-invasively evaluating the constituents in the blood of a patient comprising the steps of:

illuminating the target tissue with at least one wavelength of light at a power less than the Raman threshold;

monitoring the response of the tissue to the reflected light;

illuminating the target tissue with narrowband light having a power higher than the Raman threshold;

monitoring the Raman spectral response to the narrowband light;

correcting the Raman spectral response using the monitored response to the light having a power less than the Raman threshold; and

evaluating the constituents in the blood using the corrected Raman spectral response.

28. A method as recited in claim 27, further including the steps of:

measuring the incident intensity of the light which was at a power less than the Raman threshold; and

normalizing the response of the tissue of the reflected light based on the measurement of the intensity of the incident light.

29. A method as recited in claim 27, wherein the constituent is glucose.

30. A method as recited in claim 27, wherein the wavelength of the light having a power less than the Raman threshold is selected to either match the narrow band light having a power higher than the Raman threshold or fall within the range of the Raman shifted wavelengths.

31. An apparatus as recited in claim 27, wherein the target tissue is illuminate with a plurality of distinct wavelengths each having a power less than the Raman threshold and wherein the Raman spectral response is corrected using measurements at more than one wavelength.